The value of methotrexate in dermatomyositis
Open Access
- 31 January 1998
- journal article
- other
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (1) , 130-132
- https://doi.org/10.1016/s0190-9622(98)70562-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisalBritish Journal of Dermatology, 2006
- -Is methotrexate liver toxicity modest worldwide?British Journal of Dermatology, 1996
- Is methotrexate liver toxicity modest worldwide?British Journal of Dermatology, 1996
- Review article: methotrexate in gastroenterology-dangerous villain or simply misunderstood?Alimentary Pharmacology & Therapeutics, 1996
- Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.Annals of the Rheumatic Diseases, 1996
- Methotrexate Hepatotoxicity in Psoriatics: Report of 104 Patients from Nova Scotia, with Analysis of Risks from Obesity, Diabetes and Alcohol Consumption During Long Term Follow‐UpCanadian Journal of Gastroenterology and Hepatology, 1996
- Methotrexate UpdateScandinavian Journal of Rheumatology, 1996
- Treatment of dermatomyositis with methotrexateJournal of the American Academy of Dermatology, 1995
- The cost‐effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexateArthritis & Rheumatism, 1995
- Methotrexate for Rheumatoid ArthritisArthritis & Rheumatism, 1994